• DexCom EPS for the quarter ending December 31, 2024 was $0.37, a 39.34% decline year-over-year.
• DexCom 2024 annual EPS was $1.42, a 9.23% increase from 2023.
• DexCom 2023 annual EPS was $1.3, a 58.54% increase from 2022.
• DexCom 2022 annual EPS was $0.82, a 54.72% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.